4//SEC Filing
DASSEUX JEAN LOUIS H 4
Accession 0001209191-04-008031
CIK 0001066745other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 9:58 PM ET
Size
12.1 KB
Accession
0001209191-04-008031
Insider Transaction Report
Form 4
DASSEUX JEAN LOUIS H
SrVP, Bus. Dev. & Technologies
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2004-02-05−97,358→ 122,954 total→ Common Stock (97,358 underlying) - Exercise/Conversion
Common Stock
2004-02-05+97,358→ 103,108 total - Disposition from Tender
Common Stock
2004-02-05$35.00/sh−103,108$3,608,780→ 0 total
Footnotes (6)
- [F1]The price for the acquisition of these shares of common stock range from $0.21 per share to $9.94 per share.
- [F2]Includes allocation of 144 shares of Esperion Therapeutics, Inc. Common Stock under Esperion Therapeutics, Inc. 401(k) Savings Plan.
- [F3]Disposed of pursuant to an Agreement and Plan of Merger dated December 19, 2003, as amended on January 16, 2004, by and among Esperion Therapuetics, Inc., Enzo Aquisition Corp., and Pfizer Inc., in exchange for a cash payment representing the tender offer price of $35.00 per common share.
- [F4]The options vest in sixteen cumulative quarterly installments beginning on the end of each three month period from the date of grant.
- [F5]The expiration dates of these options range from January 3, 2008 to May 12, 2012.
- [F6]Per SEC Rules for this transaction, this field is not required.
Issuer
ESPERION THERAPEUTICS INC/MI
CIK 0001066745
Entity typeother
Related Parties
1- filerCIK 0001242617
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 9:58 PM ET
- Size
- 12.1 KB